News 

Here you will find links to material that has been added to this site recently. Authors who are members of THINCS are marked with an asterisk. 

Uffe Ravnskov*, Kilmer McCully*. The real cause of cardiovascular disease. A new hypothesis explaining the many observations that are in conflict with the cholesterol hypothesis.

Duff Wilson. Harvard Medical School in Ethics Quandary. A New York Times article about Harvard medical students taught by a professor sponsored by ten drug companies.

Joel Kauffman* Benefits of Vitamin D Supplementation.

Kilmer McCully* Cholesterol. About one of our most useful and beneficial molecules.

Duane Graveline*  spacedoc.net Graveline´s homepage with lots of interesting papers and news.

Beatrice Golomb: Pharma Corruption of Medical Science. Beatrice Golomb, ass. professor in medicine at the University of   California has aimed many years researching the side effects of statin treatment. Listen to her ten minutes youtube talk!"

Sascha Dublin and coworkers. It has been claimed that statin treatment prevents pneumonia. This is of course not true. Read for example Dublin et al.s paper published in British Medical Journal

Uffe Ravnskov*: Saturated Fat is Good for You

Hannah Wallace: Interview with Uffe Ravnskov in The Faster Time: High Cholesterol is Good.

Michel de Lorgeril.* New homepage

Kilmer McCully* Your number is up! The story about atherosclerosis and its rediscovered cause.

Shane Ellison* Over the Counter Natural Cures: Take Charge of Your Health in 30 Days with 10 Lifesaving Supplements for under $10 A new book available from amazon.

Sara Holmberg and coworkers. Food Choices and Coronary Heart Disease: A population Based Cohort Study of Rural Swedish Men with 12 Years of Follow-up Yet another strong argument against the vilification of saturated fat.

Uffe Ravnskov* et al. Doubtful effect of cholesterol lowering. Rapid Response BMJ 30. sep 2009.

Uffe Ravnskov.* The Diet Argument. A chapter from his new book (In search of a publisher)

Paul Rosch* Do Statins Prevent and Treat Infections - Or Is It High Cholesterol? As usual medical journals do not accept letters questioning the benefit of statin treatment. Here is yet another example. Read also this paper in British Medical Journal

Glyn Wainwright*, Luca Mascitelli*, Mark R. Goldstein. Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes? A further warning against statin treatment

Uffe Ravnskov.* A dietary U-turn! About a new report from WHO and FAO 

Does High Cholesterol REALLY Cause Heart Disease? Interview with Uffe Ravnskov*

Myths on Cholesterol A television interview with Duane Graveline* 

Jeff Cable.* Adverse Events of Statins - An Informal Internet-based Study

Uffe Ravnskov*, Kilmer McCully* Inflammation in atherosclerosis. Roles of microbes and the lipoprotein immune system Letter to Journal of the American College of Cardiology rejected because of "space limitation"

Thomas H Maugh (LA Times): Aggressive measures to treat diabetics make many of them worse, studies show   

Jo Waters (Daily Mail): The other side of statins: They've saved countless lives - but now doctors fear for some, the side effects could be devastating.

Rebecca Smith  (The Telegraph): Health warning over statin taken by millions.

Melinda Wenner Moyer (Scientific American): Static over Statins: Should Young People without Cholesterol Problems Take Statins?

Duff Wilson (NYT): Risks Seen in Cholesterol Drug Use in Healthy People 

NewsMax Health (Reuters): Drug Companies Paid Docs Millions

Michel de Lorgeril*: Recent cholesterol-lowering drug trials: New data, new questions. After the Vioxx scandal new clinical research regulations have come into force. Trials that begin enrolment of patients after 1July 2005 must register before their start in a recognised trials registry to be considered for publication and they must be published within 90 days after the ending regardless of whether the results are positive, negative or inconclusive. Curiously, almost all of the major trials that have been published since then have failed. How can we explain the discrepancy between the older positive trials and the negative recent ones? This is a crucial question put by de Lorgeril

Luca Mascitelli*, Francesca Pezzetta. Mark Goldstein: Nonmelanoma skin cancer and statins. The epidemic of nonmelanoma skin cancer and the widespread use of statins: is there a connection? Read also our rejected letter to The Lancet about that issue.

Stephanie Seneff.* Essays on Health

Denise Minger. The China Study: Fact or Fallacy? 

Alan Cassels: Cholesterol Drugs Don’t Help The Healthy Article in The Vancouver Sun

Jo Willey: Statins Can Be Risk To Health Article in Daily Express